Description

Truxal (Chlorprothixene) Coated Tablets 50 mg. №50 Vial

Dosage: The usual adult dose is 30-75 mg daily in divided doses. Dosage should be individualized based on the condition being treated and the patient’s response.

Indications: Truxal tablets are indicated for the treatment of various psychiatric disorders, including schizophrenia, manic episodes, and severe anxiety.

Contraindications: Do not use Truxal tablets in patients with hypersensitivity to chlorprothixene or other phenothiazines. It is contraindicated in comatose or severely depressed patients.

Directions: Take Truxal tablets orally with or without food as directed by your healthcare provider. Do not crush or chew the tablets.

Truxal (chlorprothixene) has been extensively studied for its efficacy in managing various psychiatric conditions. Research published in the Journal of Clinical Psychopharmacology demonstrated the effectiveness of chlorprothixene in reducing the symptoms of schizophrenia compared to placebo.

It is important to follow the prescribed dosage and not exceed the recommended amount to avoid potential side effects.
Pharmacological Effects: Chlorprothixene exerts its antipsychotic effects by blocking dopamine receptors in the brain, leading to a reduction in psychotic symptoms. It also has sedative and anxiolytic properties, making it useful in managing anxiety disorders.
Clinical Trials: A randomized controlled trial published in the Journal of Clinical Psychiatry compared the effectiveness of chlorprothixene with other antipsychotic medications in the treatment of acute schizophrenia. The study found that chlorprothixene was as effective as other antipsychotics with a favorable side effect profile.